Literature DB >> 1870435

Mycolic acid-containing glycolipid as a possible virulence factor of Rhodococcus equi for mice.

K Gotoh1, M Mitsuyama, S Imaizumi, I Kawamura, I Yano.   

Abstract

By the use of various Rhodococcus equi strains differing in the length of carbon chains of glycolipid, we examined whether the glycolipid, glucose monomycolate, was contributing to the virulence of R. equi for mice. R. equi strains with longer carbon chain mycolic acid showed a higher virulence as determined by lethality and granuloma formation in mice than those with shorter ones. When purified glycolipid was injected into mice, granuloma formation and liver damage were most prominent with the glycolipid having longer carbon chain mycolic acid. Only a representative strain with longer carbon chain mycolic acid persisted in the spleen of mice after intravenous injection, while a strain with shorter carbon chain mycolic acid was readily eliminated. These results suggested that glycolipid was at least one of the virulence factors of R. equi and that the carbon chain length of mycolic acid might be critical in the expression of virulence.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1870435     DOI: 10.1111/j.1348-0421.1991.tb01546.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  12 in total

1.  Fatty acid characterization of rapidly growing pathogenic aerobic actinomycetes as a means of identification.

Authors:  A McNabb; R Shuttleworth; R Behme; W D Colby
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

2.  Role of the 85-kilobase plasmid and plasmid-encoded virulence-associated protein A in intracellular survival and virulence of Rhodococcus equi.

Authors:  S Giguère; M K Hondalus; J A Yager; P Darrah; D M Mosser; J F Prescott
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

3.  Virulence of Rhodococcus equi isolates from patients with and without AIDS.

Authors:  S Takai; Y Sasaki; T Ikeda; Y Uchida; S Tsubaki; T Sekizaki
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

4.  Correlation between antibiotic resistance, phage-like particle presence, and virulence in Rhodococcus equi human isolates.

Authors:  P Nordmann; M Keller; F Espinasse; E Ronco
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

5.  Survival and replication of Rhodococcus equi in macrophages.

Authors:  M K Hondalus; D M Mosser
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

Review 6.  The medically important aerobic actinomycetes: epidemiology and microbiology.

Authors:  M M McNeil; J M Brown
Journal:  Clin Microbiol Rev       Date:  1994-07       Impact factor: 26.132

7.  Necrotic death of Rhodococcus equi-infected macrophages is regulated by virulence-associated plasmids.

Authors:  Anja Lührmann; Norman Mauder; Tobias Sydor; Eugenia Fernandez-Mora; Jan Schulze-Luehrmann; Shinji Takai; Albert Haas
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

8.  Validation of a CD1b tetramer assay for studies of human mycobacterial infection or vaccination.

Authors:  Erik D Layton; Krystle K Q Yu; Malisa T Smith; Thomas J Scriba; Stephen C De Rosa; Chetan Seshadri
Journal:  J Immunol Methods       Date:  2018-04-21       Impact factor: 2.303

9.  Differential effects of Mycobacterium bovis--derived polar and apolar lipid fractions on bovine innate immune cells.

Authors:  Chris Pirson; Gareth J Jones; Sabine Steinbach; Gurdyal S Besra; H Martin Vordermeier
Journal:  Vet Res       Date:  2012-06-27       Impact factor: 3.683

Review 10.  Rhodococcus equi and Arcanobacterium haemolyticum: two "coryneform" bacteria increasingly recognized as agents of human infection.

Authors:  R Linder
Journal:  Emerg Infect Dis       Date:  1997 Apr-Jun       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.